Trial
NCT02332889
Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Louisville
Collaborators
—
Condition
Gliomas
Intervention
Vaccine (autologous dendritic cells)
Why stopped
Transition to a different immunotherapy strategy in the future at our institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-04